Recent Posts

• Order 818 Implemented: IP Protection Strategies for Innovative Drugs under the “Dual-Track System” of Cell Therapy
• Recent overseas transaction review: Which targets are being fiercely sought after by multinational pharmaceutical companies?
• Gene Therapy for Chronic Hepatitis B: From Direct cccDNA Control to a Single-Administration Functional Cure
• Inventiveness of crystal type patents as seen in the invalidation case of “fruquintinib crystal form.”
• From “Intellectual Property” to “Assets”: Intellectual Property is the Backbone of Biopharmaceutical R&D